- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04183673
Laser + Cryo-thermal Therapy Following Total Knee Replacement Surgery
Efficacy of Laser + Cryo-thermal Therapy in Rehabilitation Following Total Knee Replacement Surgery: a Randomized Controlled Trial
Objective To investigate the effectiveness of the use of the QMD Helios Laser device in association with standard rehabilitation therapy in reducing inflammatory symptoms in patients following total knee replacement.
Design Randomized controlled trial. Setting Rehabilitation structure, inpatient Main outcome measures Pain subscale of the WOMAC and Lequesne's Algo-Functional Index (LIKERT scale), knee circumference (measured at the middle line of the knee joint space) and knee flexion /extension range of motion by goniometer.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pavia
-
Montescano, Pavia, Italy, 27040
- ICS Maugeri, Montescano Rehabilitation Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- good general physical conditions
- first total knee replacement
Exclusion Criteria:
- diabetic neuropathy
- renal or hearth disease
- allergic reactions
- Reynaud's disease
- lupus
- rheumatoids arthritis
- peripheral vascular disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Laser-cryo-usual care
Sessions 5 days a week for 3 weeks.
Each session includes laser therapy+ cryo-thermal followed by standard rehabilitation program
|
5 days per week, 3 weeks, sessions including laser therapy + cryo therapy followed by usual rehabilitation
|
|
Active Comparator: usual care
Sessions 5 days a week for 3 weeks.
Each session includes only standard rehabilitation program
|
5 days per week, 3 weeks, sessions of usual rehabilitation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Womac Pain subscale
Time Frame: Before treatment (admission) and after treatment (3 weeks after admission)
|
Pain subscale of the Western Ontario and McMaster Universities Activity Index (scored on a five point (0-4) LIKERT scale)
|
Before treatment (admission) and after treatment (3 weeks after admission)
|
|
Change in knee circumference
Time Frame: Before treatment (admission) and after treatment (3 weeks after admission)
|
Knee circumference measured at the middle line of the knee joint space
|
Before treatment (admission) and after treatment (3 weeks after admission)
|
|
Change in Lequesne's algo Functional Index
Time Frame: Before treatment (admission) and after treatment (3 weeks after admission)
|
Lequesne's algo Functional Index (scored on a five point (0-4) LIKERT scale)
|
Before treatment (admission) and after treatment (3 weeks after admission)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2200 CE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.